These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11694204)

  • 1. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.
    Markou A; Paterson NE
    Nicotine Tob Res; 2001 Nov; 3(4):361-73. PubMed ID: 11694204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Bishnoi M; van Tuijl IA; Keijzers KF; Yavarovich KR; Pasek TM; Ford J; Alexander JC; Yamada H
    Psychopharmacology (Berl); 2010 Dec; 212(4):485-99. PubMed ID: 20697697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
    Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
    Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.
    Panagis G; Kastellakis A; Spyraki C; Nomikos G
    Psychopharmacology (Berl); 2000 May; 149(4):388-96. PubMed ID: 10867966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
    Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
    Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of withdrawal from intermittent and continuous nicotine exposure on reward deficit and somatic aspects of nicotine withdrawal and expression of α4β2* nAChRs in Wistar male rats.
    Semenova S; Jin X; McClure-Begley TD; Tadman MP; Marks MJ; Markou A
    Pharmacol Biochem Behav; 2018 Aug; 171():54-65. PubMed ID: 29908200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with the vasopressin 1b receptor antagonist SSR149415 prevents the dysphoria associated with nicotine withdrawal in rats.
    Qi X; Guzhva L; Ji Y; Bruijnzeel AW
    Behav Brain Res; 2015 Oct; 292():259-65. PubMed ID: 26112757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Nicotine Intake and Reward Function in Rats With Intermittent Short Versus Long Access to Nicotine.
    Geste JR; Levin B; Wilks I; Pompilus M; Zhang X; Esser KA; Febo M; O'Dell L; Bruijnzeel AW
    Nicotine Tob Res; 2020 Feb; 22(2):213-223. PubMed ID: 30958557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
    Paterson NE; Balfour DJ; Markou A
    Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.
    O'Dell LE; Bruijnzeel AW; Smith RT; Parsons LH; Merves ML; Goldberger BA; Richardson HN; Koob GF; Markou A
    Psychopharmacology (Berl); 2006 Jul; 186(4):612-9. PubMed ID: 16598454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit.
    Salas R; Main A; Gangitano D; De Biasi M
    Neuropharmacology; 2007 Dec; 53(7):863-9. PubMed ID: 17920082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic decreases in brain reward function during nicotine withdrawal.
    Epping-Jordan MP; Watkins SS; Koob GF; Markou A
    Nature; 1998 May; 393(6680):76-9. PubMed ID: 9590692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs.
    Lindblom N; de Villiers SH; Semenova S; Kalayanov G; Gordon S; Schilström B; Johansson AM; Markou A; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):182-94. PubMed ID: 16292514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.